Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del -gating and F508del -residual function genotypes: results from an open-label extension study
James F. Chmiel, Kimberly McBennett, Bradley S. Quon, Carla Colombo et autres
us, ca, it, be, fr, es, au, de, ie, gb (code pays fourni par la source)
0 citations
Annals of the American Thoracic Society